Rafik El Beblawy, internal medicine physician and hospitalist, shared a post on X:
“Excited to share our editorial commentary in Journal of Thoracic Disease on the AEGEAN trial and the evolving role of perioperative immunotherapy in resectable NSCLC.”
Title: Efficacy without compromising resection: surgical outcomes from AEGEAN
Authors: Rafik ElBeblawy, Chinmay T. Jani, Sanad Alhushki, Aakash Desai
Read the Full Article.
